Iqstel Inc current report, 14 July 2020

Business Context and Reporting Period

This Form 8-K Current Report was filed by iQSTEL Inc. on July 14, 2020, regarding events occurring on that date. The company is incorporated in Nevada and is headquartered in Coral Gables, Florida. The filing details the entry into material definitive agreements involving equity and debt financing with Alpha Capital Anstalt.

Key Financial Metrics and Transaction Details

  • Equity Proceeds: The company issued and sold 2,000,000 shares of common stock for total proceeds of $160,000.
  • Share Price: Shares were sold at $0.08 per share, reflecting a 20% discount from the $0.10 purchase price.
  • Debt Instrument: A convertible promissory note with a principal amount of $200,000 was executed.
  • Net Debt Proceeds: The company received $160,000 from the note after a $40,000 original issue discount (OID).
  • Note Terms: The note bears 5% annual interest and matures one year from issuance.
  • Warrant Issuance: A warrant to purchase 2,000,000 shares was issued at an exercise price of $0.02 per share, expiring six months from issuance.

Material Changes and Transaction Structure

The filing reports a significant capital raise event rather than a change in operating performance. The transaction structure involved a simultaneous equity sale and debt issuance to the same purchaser. The equity portion was sold pursuant to a qualified offering circular on Form 1-A. The debt portion includes a conversion feature allowing the purchaser to convert the note into common stock after 180 days at a price of the lesser of $0.025 or 40% of the lowest trading price in the 20 days preceding issuance.

Guidance, Risks, and Contingencies

The filing does not provide specific forward-looking guidance, revenue outlook, or management commentary regarding future operations. The primary risk disclosed is the dilution of existing shareholders due to the issuance of 2,000,000 new shares and the potential conversion of the $200,000 note and exercise of the warrant for an additional 2,000,000 shares. The filing explicitly states that the description of the agreements is subject to the full text of the exhibits.

Investor Verification Checklist

  • Verify the total number of shares outstanding post-transaction to assess dilution impact.
  • Review the full text of the Securities Purchase Agreement (Exhibit 10.1) for additional covenants or restrictions.
  • Confirm the current trading price of the stock to evaluate the conversion price floor ($0.025) and warrant exercise price ($0.02).
  • Check the company's cash position to determine if the $320,000 in total gross proceeds ($160k equity + $160k net debt) is sufficient for near-term liquidity needs.
  • Review the Form 1-A offering circular referenced in the filing for historical financial data not included in this 8-K.